GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (STU:NG2) » Definitions » Stock Based Compensation

Neogen (STU:NG2) Stock Based Compensation : €13.9 Mil (TTM As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Neogen Stock Based Compensation?

Neogen's Stock Based Compensation for the three months ended in Aug. 2024 was €3.6 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Aug. 2024 was €13.9 Mil.


Neogen Stock Based Compensation Historical Data

The historical data trend for Neogen's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Stock Based Compensation Chart

Neogen Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.93 5.30 6.76 9.37 12.74

Neogen Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 3.24 3.41 3.64 3.61

Neogen Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.9 Mil.


Neogen Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Neogen's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Neogen Headlines

No Headlines